Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea
Saturday, May 20, 2023Neurocrine Biosciences Inc Nasdaq NBIX today announced that the complete study results from its Phase KINECTHD study investigating valbenazine for the treatment of chorea associated with Huntingtons disease HD has been published in The Lancet Neurol...
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics
Friday, May 19, 2023Shanghai Stock Exchange listed company HitGen Inc HitGen SSE SH announced today that it has entered into a research agreement with ARase Therapeutics Inc ARase a biotechnology company developing firstinclass therapeutics targeting ADPribose hydrolase...
Atlas Signs Definitive Agreement to Acquire an Additional Pharmacy and Provides Update on Expanding its Global Cannabis Footprint and Progressing Its International Value Chain Strategy
Friday, May 19, 2023Atlas Global Brands Inc Atlas Global Atlas or the Company CSE ATL a cannabis company with expertise across the value chain announces that it has entered into a definitive agreement Proposed Transaction signed May for the acquisition of of the outs...
Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals
Friday, May 19, 2023Biodexa Pharmaceuticals PLC NASDAQ BDRX Biodexa or the Company a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain is pleased to announce that it has signed nonbinding lett...
Alimera Acquires U.S. Commercial Rights to YUTIQ®
Friday, May 19, 2023Alimera Sciences Inc Nasdaq ALIM Alimera a global pharmaceutical company whose mission is to be invaluable to patients physicians and partners concerned with retinal health and maintaining better vision longer today announced its acquisition of addit...
ITolerance, Inc. and Kadimastem Enter into Collaboration Agreement for Development of a Potential Cure for Type 1 Diabetes and Receive US $1.0 Million Grant from the BIRD Foundation
Friday, May 19, 2023ITolerance Inc iTolerance or the Company an earlystage regenerative medicine company developing technologies to enable tissue organoid or cell therapy without the need for lifelong immunosuppression today announced that it has entered into a research...
ImmunoForge Expands Drug Development Licensing Agreement with Duke University
Friday, May 19, 2023ImmunoForge has announced on the th that it has expanded its license rights with Duke University to enhance joint research and drug development opportunities in relation to the elastinlike polypeptide ELP platform technology Through this agreement Im...
KSQ Therapeutics And Takeda Expand Strategic Immuno-Oncology Collaboration To Identify And Validate Novel Tumor Targets
Thursday, May 18, 2023KSQ Therapeutics KSQ a clinicalstage biotechnology company developing cancer therapies using its proprietary CRISPRomics discovery platform announced today that it has expanded its strategic collaboration with Takeda to research and validate novel tu...
AmbioPharm Provides an Update on South Carolina Headquarters Expansion
Thursday, May 18, 2023AmbioPharm a worldwide leader in peptide API CDMO services continues growth to meet capacity demands for late phase and commercial peptide production while increasing our sustainability efforts In order to meet customer needs we continue to make stat...
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
Thursday, May 18, 2023Avextra AG Avextra or the Company a leading verticallyintegrated manufacturer of cannabisbased medicines located in Germany is pleased to announce the successful export of its standardised cannabis extracts to Italy This is a significant achievement...
